BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6431334)

  • 21. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.
    Wheelock J; Hancock K; Smith K
    Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiotherapeutic management of ovarian cancer.
    Dembo AJ
    Semin Oncol; 1984 Sep; 11(3):238-50. PubMed ID: 6435249
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group].
    Conte PF; Rosso R; Bruzzone M; Sertoli MR; Rubagotti A; Santi L; Carnino F; Cottini M; Mossetti C; Gatti M
    Minerva Ginecol; 1984 Apr; 36(4):213-6. PubMed ID: 6547773
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.
    Sessa C; Colombo N; Bolis G; Marsoni S; Mangioni C
    Cancer Treat Rev; 1991 Mar; 18 Suppl A():37-46. PubMed ID: 1904308
    [No Abstract]   [Full Text] [Related]  

  • 25. Hexamethylmelamine, methotrexate and 5-fluorouracil (HMF) for progressive ovarian carcinoma during therapy with cis-platinum, cyclophosphamide +/- doxorubicin.
    Carlson JA; Day TG; Botts B; Masterson BJ
    Gynecol Oncol; 1985 Oct; 22(2):189-94. PubMed ID: 3932141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapy.
    Grosh WW; Jones HW; Burnett LS; Greco FA
    Gynecol Oncol; 1986 Nov; 25(3):334-9. PubMed ID: 3023205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of cisplat based chemotherapy on advanced ovarian cancer.
    Prasad GR; Dalal AV; Tongaonkar HB; Chatterjee S; Kamat MR
    J Postgrad Med; 1995; 41(4):95-8. PubMed ID: 10707728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of anthracyclines in first line combination chemotherapy of ovarian carcinoma.
    Conte PF
    Bull Cancer; 1993 Feb; 80(2):152-5. PubMed ID: 8173167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altretamine.
    Hansen LA; Hughes TE
    DICP; 1991 Feb; 25(2):146-52. PubMed ID: 1905441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
    Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
    Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal chemotherapy for advanced ovarian cancer.
    Lucas WE; Markman M; Howell SB
    Am J Obstet Gynecol; 1985 Jun; 152(4):474-8. PubMed ID: 3925784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 33. [Palliative chemotherapy of endometrial cancer. Value of combinations with doxorubicin and cisplatin].
    Chauvergne J; Granger C; Mage P; Pigneux J; David M
    Rev Fr Gynecol Obstet; 1986 Oct; 81(10):547-51. PubMed ID: 2431448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive debulking surgery as adjuvant to chemotherapy in advanced epithelial ovarian cancer.
    Onnis A; Maggino T
    Clin Exp Obstet Gynecol; 1984; 11(1-2):21-6. PubMed ID: 6424969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A carcinosarcoma of the ovary: a case report and a review].
    Ishihara H; Kanamori Y; Morishita K; Minagawa Y; Kigawa J; Matsui K
    Gan No Rinsho; 1990 Sep; 36(11):2105-9. PubMed ID: 2232179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current role of chemotherapy in the treatment of adenocarcinomas of the endometrium].
    Chauvergne J; Avril A; Pigneux J; Mage P; Granger C
    Bull Cancer; 1986; 73(6):675-9. PubMed ID: 3105628
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemotherapy of ovarian tumors using cis-platin].
    Laurová L; Kobilková J; Novotná J; Motlík K; Fricová M; Hornický J
    Cesk Gynekol; 1987 Feb; 52(1):41-4. PubMed ID: 3568161
    [No Abstract]   [Full Text] [Related]  

  • 38. Hexamethylmelamine, doxorubicin, and cyclophosphamide in advanced ovarian cancer resistant to previous chemotherapy.
    Sessa C; Bolis G; Valente I; Mangioni C; D'Incalci M
    Cancer Treat Rep; 1981; 65(1-2):172-3. PubMed ID: 6784922
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized study of sequential versus alternating combination chemotherapy in advanced ovarian carcinoma.
    Lund B; Hansen M; Hansen HH; Thomsen HK; Sørensen BL; Nielsen NC; Lundvall F
    Ann Oncol; 1990; 1(2):134-40. PubMed ID: 2127690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma of the small intestine presenting as an ovarian mass. A case report.
    Niemiec TR; Senekjian EK; Montag AG
    J Reprod Med; 1989 Nov; 34(11):917-20. PubMed ID: 2585394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.